Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1409 | 2579 | 48.1 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HSP90 | Author keyword | 293 | 41% | 21% | 553 |
2 | GELDANAMYCIN | Author keyword | 168 | 56% | 8% | 203 |
3 | HSP90 INHIBITORS | Author keyword | 93 | 74% | 3% | 70 |
4 | HEAT SHOCK PROTEIN 90 | Author keyword | 73 | 37% | 6% | 157 |
5 | 17 AAG | Author keyword | 67 | 60% | 3% | 74 |
6 | HSP90 INHIBITOR | Author keyword | 66 | 66% | 2% | 61 |
7 | CDC37 | Author keyword | 39 | 63% | 2% | 40 |
8 | SNX 2112 | Author keyword | 35 | 89% | 1% | 16 |
9 | RADICICOL | Author keyword | 32 | 50% | 2% | 46 |
10 | 17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN | Author keyword | 27 | 76% | 1% | 19 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HSP90 | 293 | 41% | 21% | 553 | Search HSP90 | Search HSP90 |
2 | GELDANAMYCIN | 168 | 56% | 8% | 203 | Search GELDANAMYCIN | Search GELDANAMYCIN |
3 | HSP90 INHIBITORS | 93 | 74% | 3% | 70 | Search HSP90+INHIBITORS | Search HSP90+INHIBITORS |
4 | HEAT SHOCK PROTEIN 90 | 73 | 37% | 6% | 157 | Search HEAT+SHOCK+PROTEIN+90 | Search HEAT+SHOCK+PROTEIN+90 |
5 | 17 AAG | 67 | 60% | 3% | 74 | Search 17+AAG | Search 17+AAG |
6 | HSP90 INHIBITOR | 66 | 66% | 2% | 61 | Search HSP90+INHIBITOR | Search HSP90+INHIBITOR |
7 | CDC37 | 39 | 63% | 2% | 40 | Search CDC37 | Search CDC37 |
8 | SNX 2112 | 35 | 89% | 1% | 16 | Search SNX+2112 | Search SNX+2112 |
9 | RADICICOL | 32 | 50% | 2% | 46 | Search RADICICOL | Search RADICICOL |
10 | 17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN | 27 | 76% | 1% | 19 | Search 17+ALLYLAMINO+17+DEMETHOXYGELDANAMYCIN | Search 17+ALLYLAMINO+17+DEMETHOXYGELDANAMYCIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GELDANAMYCIN | 379 | 63% | 15% | 384 |
2 | HEAT SHOCK PROTEIN 90 | 221 | 56% | 10% | 266 |
3 | 17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN | 208 | 74% | 6% | 153 |
4 | SHOCK PROTEIN 90 | 204 | 68% | 7% | 181 |
5 | HSP90 MOLECULAR CHAPERONE | 155 | 61% | 6% | 165 |
6 | MOLECULAR CHAPERONE HSP90 | 136 | 81% | 3% | 83 |
7 | IMPORTANT BIOLOGIC ACTIVITIES | 135 | 97% | 1% | 37 |
8 | HSP90 | 128 | 25% | 18% | 452 |
9 | ESCHERICHIA COLI HSP90 | 122 | 84% | 3% | 67 |
10 | HEAT SHOCK PROTEIN 90 INHIBITORS | 96 | 87% | 2% | 47 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Targeting the dynamic HSP90 complex in cancer | 2010 | 471 | 156 | 65% |
HSP90 at the hub of protein homeostasis: emerging mechanistic insights | 2010 | 465 | 172 | 55% |
HSP90 and the chaperoning of cancer | 2005 | 1068 | 137 | 69% |
Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers | 2012 | 99 | 79 | 91% |
Inhibition of HSP90 molecular chaperones: moving into the clinic | 2013 | 56 | 62 | 81% |
Structure and mechanism of the Hsp90 molecular chaperone machinery | 2006 | 499 | 116 | 72% |
HSP90 Inhibitors: Current Development and Potential in Cancer Therapy | 2014 | 14 | 142 | 74% |
The chaperone Hsp90: changing partners for demanding clients | 2013 | 46 | 97 | 77% |
Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions | 2013 | 46 | 54 | 76% |
The Hsp90 chaperone machinery | 2008 | 271 | 73 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SIGNAL TRANSDUCT MOL PHARMACOL TEAM | 12 | 63% | 0.5% | 12 |
2 | CANC UK CANC THER EUT | 11 | 21% | 1.7% | 45 |
3 | SECT STRUCT BIOL | 9 | 20% | 1.6% | 42 |
4 | PROGRAM MOL PHARMACOL CHEM | 9 | 23% | 1.2% | 32 |
5 | UROL ONCOL BRANCH | 7 | 10% | 2.4% | 63 |
6 | PHARMACEUT OPT SPECT | 7 | 67% | 0.2% | 6 |
7 | GUANGZHOU JINAN BIOMED DEV | 5 | 33% | 0.5% | 12 |
8 | HADDOW S | 5 | 12% | 1.4% | 35 |
9 | PROT FOLDING GRP | 4 | 67% | 0.2% | 4 |
10 | BIOMED RUMENTAT TECHNOL | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176220 | SANSALVAMIDE A//URUKTHAPELSTATIN A//PL EXPT GENOM |
2 | 0.0000108616 | SORCIN//TRAP1//HAISHENGSU |
3 | 0.0000083748 | BAG 1//BAG3//DR H BLISS MURPHY CANC |
4 | 0.0000081773 | DNAJ//GRPE//DNAK |
5 | 0.0000074415 | HSP27//HEAT SHOCK PROTEIN 27//CHAPERONOTHERAPY |
6 | 0.0000074359 | HYPOTHEMYCIN//RESORCYLIC ACID LACTONE//CURVULARIN |
7 | 0.0000068880 | HSF1//HEAT SHOCK FACTOR//HEAT SHOCK FACTOR 1 |
8 | 0.0000058123 | GP96//IMMUNOTHER Y CANC INFECT DIS//CHAPEROKINE |
9 | 0.0000056883 | REPTIN//PONTIN//R2TP |
10 | 0.0000053776 | ACTINOSYNNEMA PRETIOSUM//ANSAMITOCINS//ANSAMITOCIN |